Screener
Veradermics MANE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Veradermics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
| (in thousands, except share and per share amounts) | As of March 31, 2026 | As of December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $168,412 | $21,766 |
| Marketable securities at fair value | 222,385 | 120,096 |
| Prepaid expenses and other current assets | 6,272 | 10,632 |
| Total current assets | 397,069 | 152,494 |
| Long-term assets: | ||
| Property, plant and equipment, net | 21 | 22 |
| Right-of-use asset and other long-term assets | 266 | 103 |
| Total non-current assets | 287 | 125 |
Item 1. Condensed Consolidated Financial Statements (
FAQ
- What is Veradermics's total current assets?
- Veradermics (MANE) reported total current assets of $397.07M in Q1 2026.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Veradermics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude